Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Dampening enthusiasm for circulating microRNA in breast cancer.

Leidner RS, Li L, Thompson CL.

PLoS One. 2013;8(3):e57841. doi: 10.1371/journal.pone.0057841. Epub 2013 Mar 5.

2.

Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.

Schrauder MG, Strick R, Schulz-Wendtland R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A, Hein A, Bayer CM, Bani MR, Richter S, Adamietz BR, Wenkel E, Rauh C, Beckmann MW, Fasching PA.

PLoS One. 2012;7(1):e29770. doi: 10.1371/journal.pone.0029770. Epub 2012 Jan 5.

3.

Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.

Kodahl AR, Lyng MB, Binder H, Cold S, Gravgaard K, Knoop AS, Ditzel HJ.

Mol Oncol. 2014 Jul;8(5):874-83. doi: 10.1016/j.molonc.2014.03.002. Epub 2014 Mar 16.

4.

Circulating microRNAs as specific biomarkers for breast cancer detection.

Ng EK, Li R, Shin VY, Jin HC, Leung CP, Ma ES, Pang R, Chua D, Chu KM, Law WL, Law SY, Poon RT, Kwong A.

PLoS One. 2013;8(1):e53141. doi: 10.1371/journal.pone.0053141. Epub 2013 Jan 3.

5.

Analysis of serum genome-wide microRNAs for breast cancer detection.

Wu Q, Wang C, Lu Z, Guo L, Ge Q.

Clin Chim Acta. 2012 Jul 11;413(13-14):1058-65. doi: 10.1016/j.cca.2012.02.016. Epub 2012 Feb 23.

PMID:
22387599
6.

Identification of circulating microRNA signatures for breast cancer detection.

Chan M, Liaw CS, Ji SM, Tan HH, Wong CY, Thike AA, Tan PH, Ho GH, Lee AS.

Clin Cancer Res. 2013 Aug 15;19(16):4477-87. doi: 10.1158/1078-0432.CCR-12-3401. Epub 2013 Jun 24.

7.

Overexpression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patients.

Kumar S, Keerthana R, Pazhanimuthu A, Perumal P.

Indian J Biochem Biophys. 2013 Jun;50(3):210-4.

PMID:
23898484
8.

Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers.

van Schooneveld E, Wouters MC, Van der Auwera I, Peeters DJ, Wildiers H, Van Dam PA, Vergote I, Vermeulen PB, Dirix LY, Van Laere SJ.

Breast Cancer Res. 2012 Feb 21;14(1):R34.

9.

Next-generation sequencing of microRNAs for breast cancer detection.

Wu Q, Lu Z, Li H, Lu J, Guo L, Ge Q.

J Biomed Biotechnol. 2011;2011:597145. doi: 10.1155/2011/597145. Epub 2011 May 26.

10.

Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.

Matamala N, Vargas MT, González-Cámpora R, Miñambres R, Arias JI, Menéndez P, Andrés-León E, Gómez-López G, Yanowsky K, Calvete-Candenas J, Inglada-Pérez L, Martínez-Delgado B, Benítez J.

Clin Chem. 2015 Aug;61(8):1098-106. doi: 10.1373/clinchem.2015.238691. Epub 2015 Jun 8.

PMID:
26056355
11.

Serum circulating microRNA profiling for identification of potential breast cancer biomarkers.

Mar-Aguilar F, Mendoza-Ramírez JA, Malagón-Santiago I, Espino-Silva PK, Santuario-Facio SK, Ruiz-Flores P, Rodríguez-Padilla C, Reséndez-Pérez D.

Dis Markers. 2013;34(3):163-9. doi: 10.3233/DMA-120957.

12.

De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer.

Wu X, Somlo G, Yu Y, Palomares MR, Li AX, Zhou W, Chow A, Yen Y, Rossi JJ, Gao H, Wang J, Yuan YC, Frankel P, Li S, Ashing-Giwa KT, Sun G, Wang Y, Smith R, Robinson K, Ren X, Wang SE.

J Transl Med. 2012 Mar 8;10:42. doi: 10.1186/1479-5876-10-42.

13.

MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers.

Zearo S, Kim E, Zhu Y, Zhao JT, Sidhu SB, Robinson BG, Soon PSh.

BMC Cancer. 2014 Mar 18;14:200. doi: 10.1186/1471-2407-14-200.

14.

A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer.

Zhao H, Shen J, Medico L, Wang D, Ambrosone CB, Liu S.

PLoS One. 2010 Oct 29;5(10):e13735. doi: 10.1371/journal.pone.0013735.

15.

Clinical evaluation of microRNA expression profiling in non small cell lung cancer.

Markou A, Sourvinou I, Vorkas PA, Yousef GM, Lianidou E.

Lung Cancer. 2013 Sep;81(3):388-96. doi: 10.1016/j.lungcan.2013.05.007. Epub 2013 Jun 10.

PMID:
23756108
16.

microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.

Brunet Vega A, Pericay C, Moya I, Ferrer A, Dotor E, Pisa A, Casalots À, Serra-Aracil X, Oliva JC, Ruiz A, Saigí E.

Oncol Rep. 2013 Jul;30(1):320-6. doi: 10.3892/or.2013.2475. Epub 2013 May 15.

PMID:
23673725
17.

The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers.

Chen W, Cai F, Zhang B, Barekati Z, Zhong XY.

Tumour Biol. 2013 Feb;34(1):455-62. doi: 10.1007/s13277-012-0570-5. Epub 2012 Dec 14.

PMID:
23238818
18.

Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer.

Si H, Sun X, Chen Y, Cao Y, Chen S, Wang H, Hu C.

J Cancer Res Clin Oncol. 2013 Feb;139(2):223-9. doi: 10.1007/s00432-012-1315-y. Epub 2012 Sep 30.

19.

Alterations in circulating miRNA levels following early-stage estrogen receptor-positive breast cancer resection in post-menopausal women.

Kodahl AR, Zeuthen P, Binder H, Knoop AS, Ditzel HJ.

PLoS One. 2014 Jul 8;9(7):e101950. doi: 10.1371/journal.pone.0101950. eCollection 2014.

20.

U6 is not a suitable endogenous control for the quantification of circulating microRNAs.

Xiang M, Zeng Y, Yang R, Xu H, Chen Z, Zhong J, Xie H, Xu Y, Zeng X.

Biochem Biophys Res Commun. 2014 Nov 7;454(1):210-4. doi: 10.1016/j.bbrc.2014.10.064. Epub 2014 Oct 18.

PMID:
25450382
Items per page

Supplemental Content

Write to the Help Desk